PCDHB1: A Transmembrane Protein with Potential as A Drug Target Or Biomarker

Target Name: PCDHB1

NCBI ID: G29930

PCDHB1

PCDHB1: A Transmembrane Protein with Potential as A Drug Target Or Biomarker

PCDHB1 (Protocadherin beta-1) is a transmembrane protein that is expressed in various tissues throughout the body. It plays a crucial role in cell-cell adhesion and tissue organization, and is involved in many physiological processes, including embryonic development, tissue repair, and cancer progression.

Recent studies have identified PCDHB1 as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is due to PCDHB1's unique structure and biology, as well as its expressed expression in a wide range of tissues and cells.

One of the key reasons why PCDHB1 has been identified as a potential drug target is its role in cancer progression. Many studies have shown that PCDHB1 is highly expressed in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, PCDHB1 has been shown to promote the growth and survival of cancer cells, which may make it an attractive target for anti-cancer drugs.

Another potential drug target for PCDHB1 is its role in neurodegenerative diseases. Many neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles. PCDHB1 has been shown to be involved in the development and progression of these diseases, and may be a useful biomarker or drug target for these conditions.

In addition to its potential as a drug target, PCDHB1 has also been identified as a potential biomarker for certain diseases. For example, some studies have shown that PCDHB1 levels are elevated in individuals with Alzheimer's disease, and that levels may be reduced in individuals with normal cognitive function. This suggests that PCDHB1 may be a useful biomarker for Alzheimer's disease, and that it may be a potential target for anti-Alzheimer's drug development.

Another potential application of PCDHB1 as a biomarker is its role in tissue repair. After injury or trauma, the body often undergoes a process of tissue repair to repair damaged tissue and promote healing. PCDHB1 has been shown to be involved in this process, and may be a useful biomarker for tracking tissue repair after injury or trauma.

In conclusion, PCDHB1 is a transmembrane protein that is involved in a wide range of physiological processes throughout the body. Its unique structure and biology, as well as its expressed expression in various tissues and cells, make it an attractive target for drug development and biomarker research. As research continues to progress, it is likely that new insights into PCDHB1's role in various diseases will emerge, and it will continue to be a valuable tool for the study of these conditions.

Protein Name: Protocadherin Beta 1

Functions: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain

The "PCDHB1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCDHB1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets